Annovis Historical Balance Sheet
| ANVS Stock | USD 9.85 0.86 9.57% |
Trend analysis of Annovis BioInc balance sheet accounts such as Other Current Liab of 3.1 M, Total Current Liabilities of 3 M or Net Tangible Assets of 53.7 M provides information on Annovis BioInc's total assets, liabilities, and equity, which is the actual value of Annovis BioInc to its prevalent stockholders. By breaking down trends over time using Annovis BioInc balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Annovis BioInc Inventory |
|
Annovis |
About Annovis Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Annovis BioInc at a specified time, usually calculated after every quarter, six months, or one year. Annovis BioInc Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Annovis BioInc and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Annovis currently owns. An asset can also be divided into two categories, current and non-current.
Annovis BioInc Balance Sheet Chart
Annovis BioInc Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Annovis BioInc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Annovis BioInc's Intangible Assets are comparatively stable compared to the past year. Other Assets is likely to gain to about 662.6 K in 2024, despite the fact that Total Stockholder Equity is likely to grow to (7.4 M). Add Fundamental
Total Assets
Total assets refers to the total amount of Annovis BioInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Annovis BioInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Annovis BioInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Annovis BioInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Annovis BioInc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Annovis BioInc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most accounts from Annovis BioInc's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Annovis BioInc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.At this time, Annovis BioInc's Intangible Assets are comparatively stable compared to the past year. Other Assets is likely to gain to about 662.6 K in 2024, despite the fact that Total Stockholder Equity is likely to grow to (7.4 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 818.4K | 3.7M | 3.0M | 3.1M | Total Assets | 46.0M | 36.0M | 10.2M | 14.9M |
Annovis BioInc balance sheet Correlations
Click cells to compare fundamentals
Annovis BioInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Annovis BioInc balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 1.1M | 8.1M | 46.0M | 36.0M | 10.2M | 14.9M | |
| Other Current Liab | 776.9K | 236.5K | 818.4K | 3.7M | 3.0M | 3.1M | |
| Total Current Liabilities | 2.0M | 578.4K | 1.5M | 7.7M | 4.3M | 3.0M | |
| Total Stockholder Equity | (8.6M) | 7.5M | 44.5M | 28.3M | (7.8M) | (7.4M) | |
| Net Tangible Assets | (7.6M) | (8.6M) | 7.5M | 44.5M | 51.2M | 53.7M | |
| Retained Earnings | (8.8M) | (14.2M) | (28.7M) | (54.1M) | (110.3M) | (104.7M) | |
| Accounts Payable | 1.2M | 341.9K | 688.1K | 4.0M | 1.3M | 1.5M | |
| Cash | 1.9K | 8.1M | 45.7M | 28.4M | 5.8M | 9.4M | |
| Other Current Assets | 745.7M | 44.7M | 315.5M | 7.6B | 4.5M | 4.2M | |
| Other Stockholder Equity | 200.6K | 21.8M | 73.2M | 82.4M | 102.5M | 107.6M | |
| Total Liab | 9.7M | 578.4K | 1.5M | 7.7M | 18.0M | 18.9M | |
| Total Current Assets | 747.5K | 8.1M | 46.0M | 36.0M | 10.2M | 12.9M | |
| Net Debt | 497.9K | (8.1M) | (45.7M) | (28.4M) | (5.8M) | (6.0M) | |
| Cash And Short Term Investments | 1.9K | 8.1M | 45.7M | 28.4M | 5.8M | 5.5M | |
| Common Stock Shares Outstanding | 6.8M | 6.3M | 7.6M | 8.2M | 9.0M | 7.3M | |
| Liabilities And Stockholders Equity | 1.1M | 8.1M | 46.0M | 36.0M | 10.2M | 16.0M | |
| Non Current Liabilities Total | 7.7M | 341.9K | 688.1K | 4.0M | 13.7M | 14.4M | |
| Capital Surpluse | 192.1K | 200.6K | 21.8M | 73.2M | 84.2M | 88.4M | |
| Net Invested Capital | (8.1M) | 7.5M | 44.5M | 28.3M | (7.8M) | (7.4M) | |
| Net Working Capital | (1.3M) | 7.5M | 44.5M | 28.3M | 5.9M | 5.6M |
Pair Trading with Annovis BioInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis BioInc will appreciate offsetting losses from the drop in the long position's value.Moving against Annovis Stock
| 0.54 | GRTX | Galera Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.51 | MRSN | Mersana Therapeutics Downward Rally | PairCorr |
The ability to find closely correlated positions to Annovis BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis BioInc to buy it.
The correlation of Annovis BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Annovis BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Annovis Stock analysis
When running Annovis BioInc's price analysis, check to measure Annovis BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis BioInc is operating at the current time. Most of Annovis BioInc's value examination focuses on studying past and present price action to predict the probability of Annovis BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis BioInc's price. Additionally, you may evaluate how the addition of Annovis BioInc to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Annovis BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis BioInc. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.23) | Return On Assets (1.22) | Return On Equity (5.46) |
The market value of Annovis BioInc is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis BioInc's value that differs from its market value or its book value, called intrinsic value, which is Annovis BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis BioInc's market value can be influenced by many factors that don't directly affect Annovis BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Annovis BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.